Eton Pharmaceuticals expands rare endocrine portfolio with FDA-backed liquid desmopressin
FDA approves DESMODA oral solution for central diabetes insipidus. Explore what this means for dosing precision and rare endocrine care.
Savara selects PANTHERx as exclusive pharmacy for MOLBREEVI amid PAP BLA review
Savara names PANTHERx as exclusive pharmacy for MOLBREEVI in autoimmune PAP. Find out what this launch model means for access, adoption, and strategy.